Attachment 13 - Building 74A Walla Walla VAMC - Final Rev 1.pdf

RIMA’S TEMPLATE

p

WALLA WALLA VA MEDICAL CENTER

ASBESTOS SURVEY REPORT

BUILDING 74A

Mabbett Project No. R2019002.000.001 June 2019 Prepared for:

11031 S. Pikes Peak Drive, Suite 202 Parker, CO 80138 and

Walla Walla VA Medical Center 77 Wainwright Drive Walla Walla, WA 99362

Mabbett & Associates, Inc.

5 Alfred Circle Bedford, MA 01730-2318 T. 781-275-6050 Massachusetts | Virginia | Rhode Island | New Jersey www.mabbett.com

© 2019, Mabbett & Associates, Inc.

BUILDING 74A – ASBESTOS SURVEY REPORT

Walla Walla VA Medical Center | Walla Walla, WA

© 2019, Mabbett & Associates, Inc. i June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg 74A\Building 74A Walla Walla VAMC - Final Rev 1.doc

ACKNOWLEDGEMENT

This Asbestos Containing Material (ACM) Survey Report was prepared in accordance with an established scope of work as defined in the Mabbett Proposal No. P2018292 for AES Contract Number VA201-1901.1. The information presented herein is based on the facts and information conveyed to or received by Mabbett & Associates, Inc.

(Mabbett®) during the preparation of this report. If any of the information provided to Mabbett that was used in preparing this report is incorrect, incomplete, or subject to change, Mabbett would wish to alter its opinion(s) accordingly. In addition, the professional opinions and information contained in this report are based solely on the requirements of the applicable regulations and technical data as known to Mabbett as of the date of this report and considered applicable to this report.

This report was prepared by:

Kevin M. Donovan Environmental, Health and Safety Specialist

This report has been reviewed and approved by:

Michael F. Delaney Director, Building Sciences Group

© 2019, Mabbett & Associates, Inc. ii June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg 74A\Building 74A Walla Walla VAMC - Final Rev 1.doc

TABLE OF CONTENTS

SECTION PAGE

1.0 INTRODUCTION

2.0 BUILDING DESCRIPTION

3.0 ASBESTOS SURVEY

3.1 Sampling Methodology

3.2 Analytical Methodology

3.3 Summary of Asbestos Containing Materials (ACM) Findings

3.3.1 Drawings

4.0 LIMITATIONS

5.0 CLOSING REMARKS

TABLES

Table 1 – Summary of ACM (in text) Table 2 – Summary of ACM Sampling Results

FIGURES

Figure 1 – Asbestos Survey, Building 74A – First Floor

APPENDICES

Appendix A – Table 2, Summary of ACM Sampling Results Appendix B – Laboratory Analytical Results and Chain of Custody

© 2019, Mabbett & Associates, Inc. 1 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg 74A\Building 74A Walla Walla VAMC - Final Rev 1.doc

1.0 INTRODUCTION

Mabbett and Associates, Inc. (Mabbett®) performed surveys for suspect asbestos containing materials (ACM) of selected buildings at the Walla Walla VA Medical Center (Walla Walla VAMC) located at 77 Wainwright Drive in Walla Walla, Washington, under AES Contract Number VA201-1901.1. This report presents results of the ACM survey conducted at Building 74A. Site survey work was performed over two periods ranging from February 11, 2019 through February 15, 2019 and March 20, 2019 through March 21, 2019, by appropriately credentialed regulated building materials inspectors. Bulk samples of suspected ACM were collected and submitted to a certified analytical laboratory for asbestos analysis by polarized light microscopy (PLM) using stop positive methodology. Confirmatory analysis of some samples by transmission electron microscopy (TEM) was conducted as required. The survey effort involved the collection of the following samples, resulting in the following conclusions:

Forty-seven (47) bulk samples for suspect ACM were collected in this building.

Based on laboratory analysis of suspect ACM, one (1) of the collected samples contained asbestos greater than 1%.

The Asbestos Survey was comprised of three primary project tasks including:

Evaluation of previous survey data (if available) and existing site conditions and formulation of the sampling plan.

Site survey to collect building material samples for laboratory analysis and reporting.

Interpretation of laboratory data and development of this Asbestos Survey Report.

This project deliverable is supported by a series of tables and appendices that are embedded within this report, or provided as attachments.

2.0 BUILDING DESCRIPTION

According to information provided by the VAMC and observations made by the Mabbett team at the time of the survey, Building 74A is described as the HAS Building which is a one-story structure on a concrete foundation with an asphalt shingle roof. The building is attached to building 74 and occupies approximately 2,700 square feet.

3.0 ASBESTOS SURVEY

3.1 Sampling Methodology

The Mabbett team performed a physical U.S. Environmental Protection Agency (EPA) Asbestos Hazard and Emergency Response Act (AHERA) type inspection and sampling of suspect materials as required by EPA Asbestos Hazard Emergency Response Act (AHERA) regulations (i.e. 40 CFR 763), OSHA Asbestos Standards (i.e. 29 CFR

1910.1001 & 29 CFR 1926.1101) and the VHA Asbestos Management Directive (VHA Directive 7714).

The Walla Walla VAMC provided Mabbett with two historical asbestos inspection reports for asbestos surveys that were previously conducted at the facility. The first survey was conducted by Environmental Health Sciences, Inc. in October 1989. The second survey, which was limited in scope, was conducted by Blue Mountain Environmental & Consulting, Inc. in December 2003. These reports were reviewed by the Mabbett team prior to performing inspection activities. In some instances, ACM identified by the previous surveys was confirmed by Mabbett, reassessed and included in this Asbestos Survey Report.

A visual screening inspection was conducted to identify locations of suspect ACM throughout identified areas of the building by Asbestos Hazard and Emergency Response Act (AHERA) trained and accredited asbestos inspectors. Only

© 2019, Mabbett & Associates, Inc. 2 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg 74A\Building 74A Walla Walla VAMC - Final Rev 1.doc areas that were accessible during the field work phase were inspected. Every effort was made during the initial field survey work to access areas as necessary to complete the survey.

General areas that were inaccessible or where the survey was limited to visual observation only are identified below:

• Within walls • Within fire doors

• Enclosed pipe/duct chases •Inside mechanical equipment/ductwork

• Above fixed drywall or plaster ceilings without access panels

Due to these access restrictions, comprehensive pre-demolition ACM surveys should be performed prior to any proposed renovations or maintenance involving inaccessible areas. Roofing materials were not sampled in order to maintain applicable warranties.

Bulk samples were collected of suspect ACM in accordance with AHERA and conducted according to the following sampling plan:

a) Surfacing material:

a. At least three bulk samples were collected from each homogeneous area that is 1,000 ft2 or less.

b. At least five bulk samples were collected from each homogeneous area that is greater than 1,000 ft2 but less than or equal to 5,000 ft2.

c. At least seven bulk samples were collected from each homogeneous area that is greater than 5,000 ft2.

b) Thermal system insulation:

a. At least three bulk samples were collected from each homogeneous area of thermal system insulation.

b. At least one bulk sample was collected from each homogeneous area of patched area of thermal system insulation.

c. Sufficient samples were collected from elbows and fittings to determine if they contain ACM.

d. Bulk samples were not collected from any homogeneous area where the state licensed asbestos inspector determined that the thermal system insulation is fiberglass, foam glass, rubber, or other non-ACM.

c) Miscellaneous material:

a. At least one bulk sample was collected from each homogeneous area that is less than 100 ft2.

b. At least two bulk samples were collected from each homogeneous area that is greater than 100 ft2.

3.2 Analytical Methodology

The collected bulk samples were submitted under chain of custody procedures to ProScience of Woburn, MA.

ProScience is accredited by the American Industrial Hygiene Association (AIHA) and participates in the National Voluntary Laboratory Accreditation Program (NVLAP Lab Code 200090-0). Bulk samples were analyzed with polarized light microscopy (PLM) using EPA Method 600/R-93/116.

Bulk sample results are summarized in Table 2 – Summary of ACM Sampling Results and included as Appendix A. The EPA and the Occupational Safety and Health Administration (OSHA) defines any material that contains greater than one percent (>1%) asbestos as being an ACM. As such, the analytical laboratory identified bulk samples as positive

© 2019, Mabbett & Associates, Inc. 3 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg 74A\Building 74A Walla Walla VAMC - Final Rev 1.doc for asbestos that met the regulatory criteria of greater than or equal to one percent (≥1%) asbestos. Laboratory reports and the chain of custodies are provided in Appendix B of this report.

3.3 Summary of Asbestos Containing Materials (ACM) Findings

Mabbett sampled sixteen (16) types of homogenous materials and collected forty-seven (47) representative bulk ACM samples. Forty-six (46) samples were analyzed by PLM and one (1) sample was a positive stop and not analyzed.

The current and historical laboratory analytical data indicated that one (1) homogenous material had greater than 1% asbestos and were ACM or PACM. Estimated quantities of materials identified as ACM or PACM are presented in Table 1 below:

Table 1 Summary of ACM

Building 74A Walla Walla VAMC

Sample / Homogeneous

Area No.

Location Description of

Material

Percent and Type of Asbestos

Estimated Quantity Material

Type Condition Amount Units

12 Room 147B 12" x 12" Cream Floor Tile

2% Chrysotile 120 SF Misc. Damaged

Notes:

SF = Square Feet Misc. = Miscellaneous Material

3.3.1 Drawings

The location of each collected bulk sample and its sample ID is shown on the drawings in the Figures Section of this report. Each positive ACM sample location is marked with an asterisk (*), while positive stops are marked with two asterisks (**). Collected bulk samples that were not positive are identified solely by the sample ID.

4.0 LIMITATIONS

This survey report is the result of both a qualitative (visual inspection) and quantitative assessment of potential ACM in Building 74A at the Walla Walla VAMC. Although a comprehensive inspection was performed with the majority of the building accessed for evaluation and sampling purposes, Mabbett does not claim to have identified all of the materials that may be present at/in the facility due to limitations. Only accessible and authorized areas/materials were included in this survey. Mabbett has conducted this assessment with reasonable care and has performed this project within generally accepted industry standards. Mabbett makes no assurances that the information, research, and technology used to prepare this report may not change in the future, thus affecting the results reported herein.

5.0 CLOSING REMARKS

Prior to initiating plans for maintenance activities, the Walla Walla VAMC should review the asbestos survey results to determine whether any of the materials identified as ACM will be disturbed by proposed work activities. This report may not be used as a renovation/demolition Asbestos National Emission Standards for Hazardous Air Pollutants (NESHAP) type inspection report. Prior to any renovation/demolition activities, a full destructive asbestos inspection of the work area, including any previously inaccessible or unsampled materials that might be impacted, must be conducted.

© 2019, Mabbett & Associates, Inc. 4 June 2019 Project No. R2019002.000.001 S:\ADMINA\2019002 Walla Walla VAMC\000\001\Bldg 74A\Building 74A Walla Walla VAMC - Final Rev 1.doc

The purpose of this ACM survey was to identify ACM in Building 74A within the limitations of the survey for worker protection purposes and for future renovation planning. In regard to asbestos, any suspect material encountered during maintenance activities that is not identified in this report as being non-ACM should be assumed to be ACM unless laboratory analytical data for bulk samples prove otherwise. Suspect ACM that may be present within the walls, above inaccessible hard ceilings, or in other inaccessible locations, and that accordingly was not inspected, should be assumed to contain asbestos if discovered until otherwise verified, as previously described. If ACM will be disturbed, the ACM must be removed by a licensed asbestos abatement contractor and be performed in accordance with applicable regulations. If proposed work activities will not disturb intact ACM, continuous monitoring of ACM should be conducted throughout work activities to ensure the ACM remains in an intact condition. Additionally, prior to commencing work activities, all personnel involved should be made aware of the location of known ACM within the building in which they will be working.

© 2019, Mabbett & Associates, Inc. FIGURES June 2019 Project No. R2019002.000.001 Building 74A Walla Walla VAMC - Final Rev 1.doc

FIGURES

133 EXAM

EXAM

EXAM

EXAM

ELECTRICAL CLOSET

ELECT CLOS

CONFERENCE ROOM

PATIENT EDUCATION

CLEAN STORAGE

TELEPHONE CLOSET

MENS' LOCKER

HOUSEKEEPING AID CLOSED

WOMENS LOCKER

NURSES STATION

NURSES STATION

FILLING AND ASSEMBLY

MEDICAL SUPPLIES

CONTROLLED SUBSTANCE VAULT

PRESCRIPTION PICK-UP

PHARMACY

DOCUMED

PRESCRIPTION RECEIVING

TELEPHONE RM

FIRE SPRINKLER

MCCR-COPY

VENDING RM

FUNCTION

147A

147B

126 EXAM

EXAM

EXAM

116 EXAM

EXAM112

EXAM

EXAM

EXAM

109D

110 EXAM

109B

109C

109A

103 TRAVEL

ROOM#

DIETITIAN

MEDICAL INFORMATION SERVICE

MEDICAL INFORMATION SERVICE

ELECTRICAL/MECHANICAL ROOM

MEDICAL INFORMATION SERVICE

MEDICAL INFORMATION SERVICE

MEDICAL INFORMATION SERVICE

SOCIAL WORKER

SOCIAL WORKER

SUPV. AMBULATORY CARE

NURSES MANAGER

FORMS

PHYSICIAN ASSISTANT

DOCTORS LIBRARY

NURSES STATION

EXAM158

159 EXAM

EXAM

EXAM

ADMISSIONS

ADMISSIONS

MAS-PRIVACY INTERVIEW

MANUALS LIBRARY

ELEVATOR EQUIPMENT RM

EMERGENCY ROOM

WOMENS'S RESTROOM

MEN'S RESTROOM

BUILDING No. 74 - FIRST FLOOR

DIRTY UTILITY

WHEELCHAIR STORAGE

NURSES STATION

FUNCTION

136 EXAM

ROOM#

EXAM

148A

148B

74A-14C

74A-02A 74A-03A

74A-08A

74A-08B

74A-04A

74A-01B

74A-01A

74A-14A

74A-16A 74A-16B

74A-09A 74A-10A

74A-13B 74A-12B** 74A-12A* 74A-13A

74A-05C 74A-06C

74A-04B

74A-14B

74A-02C 74A-03C

74A-05B 74A-06B

74A-14E

74A-15B74A-02B 74A-03B

74A-01C74A-07A 74A-07B 74A-07C 74A-08C 74A-09B 74A-10B 74A-11A 74A-11B 74A-11C

74A-15C74A-05A 74A-06A

74A-16C

74A-14D

74A-15A

74A-09C 74A-10C

BUILDING 74

PROJECT NUMBER

BUILDING NUMBER

DRAWING NUMBER

PROJECT TITLE

LOCATION

ISSUE DATE CHECKED DRAWN

DRAWING TITLE

VA FORM 08 - 6231

A

F i l e

P a t h

Office of

Construction and Facilities

Management

U.S. Department of Veterans Affairs

B

C

D

E

F

A

B

C

D

E

F

21 4 5 6 7 8 9 10

PHASE:

ARCHITECT/ENGINEER OF RECORD

SEAL

CONSULTANT

321 4 5 6 7 8 9 10

COMPREHENSIVE BASELINE

ASBESTOS SURVEY

WALLA WALLA, WA

687-19-105 AE

APPROVED: PROJECT DIRECTOR

JUNE, 2019

REVISIONS: DATE:

Group, Inc.

11031 SOUTH PIKES PEAK DRIVE #202

PARKER, COLORADO 80138

PH: 303.841.3922

WWW.AES-GRP.COM

RECORD DRAWINGS

DWG. OF

GENERAL NOTES:

1. DRAWINGS DO NOT CLAIM TO IDENTIFY ASBESTOS CONTAINING MATERIAL

PRESENT IN THE BUILDING AND SHOULD NOT BE THE BASIS FOR IDENTIFYING

ACM FOR FUTURE RENOVATION OR DEMOLITION PROJECTS, ABATEMENT

SPECIFICATIONS, ETC. THIS SURVEY DOES NOT MEET THE REQUIREMENTS OF A

PRE-RENOVATION NESHAP SURVEY. MABBETT'S SURVEY WAS PERFORMED

WITH LIMITATIONS INHERENT TO NON-DESTRUCTIVE VISUAL INSPECTIONS IN

OCCUPIED SPACES. ANY SUSPECT MATERIAL ENCOUNTERED DURING

RENOVATION/DEMOLITION THAT IS NOT IDENTIFIED AS BEING NON-ACM SHOULD

BE ASSUMED TO BE ACM UNLESS SAMPLE RESULTS PROVE OTHERWISE.

LEGEND:

1,2

25*

25(TEM)

25**

APPROXIMATE SAMPLE LOCATION

SAMPLE GREATER THAN 1% ASBESTOS

SAMPLE GREATER THAN 1% ASBESTOS (TEM)

STOP POSITIVE SAMPLE FOR ASBESTOS

NO ASBESTOS DETECTED (NAD)

BUILDING 74A

1ST FLOOR

74A-101

74A

WBRMFD

0'

SCALE: 1/8" = 1'-0"SCALE: 1/8" = 1'-0"

16'8'4'

AutoCAD SHX Text N

© 2019, Mabbett & Associates, Inc. APPENDIX A June 2019

’S TEMPLATE

APPENDIX A

Table 2 Summary of ACM Sampling Results

© 2019, Mabbett & Associates, Inc. Appendix A Page 1 of 2 June 2019

Table 2

Summary of ACM Sampling Results Building 74A

Walla Walla VAMC Sample

No. Sample Location Description of Material Percent and Type of Asbestos

74A-01A 1st Floor - Room 147 2' x 4' White Ceiling Tile NAD 74A-01B 1st Floor - Room 147A 2' x 4' White Ceiling Tile NAD 74A-01C 1st Floor - Room 148 2' x 4' White Ceiling Tile NAD 74A-02A 1st Floor Room 147 12" x 12" Beige Floor Tile NAD 74A-02B 1st Floor Room 148 12" x 12" Beige Floor Tile NAD 74A-02C 1st Floor Room 148 12" x 12" Beige Floor Tile NAD 74A-03A 1st Floor Room 147 12" x 12" Beige Floor Tile Mastic NAD 74A-03B 1st Floor Room 148 12" x 12" Beige Floor Tile Mastic NAD 74A-03C 1st Floor Room 148 12" x 12" Beige Floor Tile Mastic NAD 74A-04A 1st Floor - Room 147A Carpet Adhesive NAD 74A-04B 1st Floor - Room 148A Carpet Adhesive NAD 74A-05A 1st Floor - Room 147 Gypsum Wallboard NAD 74A-05B 1st Floor - Room 147B Gypsum Wallboard NAD 74A-05C 1st Floor - Room 148 Gypsum Wallboard NAD 74A-06A 1st Floor - Room 147 Joint Compound NAD 74A-06B 1st Floor - Room 147B Joint Compound NAD 74A-06C 1st Floor - Room 148 Joint Compound NAD 74A-07A 1st Floor - Room 147B White Fiberglass End Sealant NAD 74A-07B 1st Floor - Room 147B White Fiberglass End Sealant NAD 74A-07C 1st Floor - Room 147B White Fiberglass End Sealant NAD 74A-08A 1st Floor - Room 147 Red Fire Stop NAD 74A-08B 1st Floor - Room 147A Red Fire Stop NAD 74A-08C 1st Floor - Room 147B Red Fire Stop NAD 74A-09A 1st Floor - Outside 147B 4" Cove Base NAD 74A-09B 1st Floor - Room 147B 4" Cove Base NAD 74A-09C 1st Floor - Room 148 4" Cove Base NAD 74A-10A 1st Floor - Outside 147B 4" Cove Base Adhesive NAD 74A-10B 1st Floor - Room 147B 4" Cove Base Adhesive NAD 74A-10C 1st Floor - Room 148 4" Cove Base Adhesive NAD 74A-11A 1st Floor - Room 147B Grey Duct Seam Sealant NAD 74A-11B 1st Floor - Room 147B Grey Duct Seam Sealant NAD 74A-11C 1st Floor - Room 147 Grey Duct Seam Sealant NAD 74A-12A 1st Floor - Room 147B 12" x 12" Cream Floor Tile 2% Chrysotile 74A-12B 1st Floor - Room 147B 12" x 12" Cream Floor Tile NA/PS 74A-13A 1st Floor - Room 147B 12" x 12" Cream Floor Tile Mastic NAD 74-13B 1st Floor - Room 147B 12" x 12" Cream Floor Tile Mastic NAD

74A-14A Exterior - North Side Stucco Siding NAD 74A-14B Exterior - East Side Stucco Siding NAD

© 2019, Mabbett & Associates, Inc. Appendix A Page 2 of 2 June 2019 Project No. R2019002.000.001 Building 74A Walla Walla VAMC - Final Rev 1.doc

Table 2 Summary of ACM Sampling Results

Building 74A Walla Walla VAMC

Sample No. Sample Location Description of Material Percent and Type of

Asbestos 74A-14C Exterior - West Side Stucco Siding NAD 74A-14D Exterior - South Side Stucco Siding NAD 74A-14E Exterior - Southeast Corner Stucco Siding NAD 74A-15A Exterior - North Side Window Frame Caulk NAD 74A-15B Exterior - Southeast Corner Window Frame Caulk NAD 74A-15C Exterior - South Side Window Frame Caulk NAD 74A-16A Exterior - North Side Expansion Joint Caulk NAD 74A-16B Exterior - North Side Expansion Joint Caulk NAD 74A-16C Exterior - South Side Expansion Joint Caulk NAD

Notes:

NAD = No Asbestos Detected NA/PS = Not Analyzed / Positive Stop

© 2019, Mabbett & Associates, Inc. APPENDIX B June 2019

APPENDIX B

Laboratory Analytical Results and Chain of Custody